Maris-Tech Ltd. Form 6-K Summary
Business Context and Reporting Period
Maris-Tech Ltd., an Israeli foreign private issuer, filed Form 6-K on March 6, 2023, reporting an amendment dated March 2, 2023, to its existing loan facility agreement. The filing covers March 2023 and does not provide operating or quarterly financial results.
Financial Metrics and Liquidity
- Total outstanding amount under the amended Loan Agreement: NIS 3,480,305.88, approximately $1.09 million.
- Amount due to director and second-largest shareholder Joseph Gottlieb: NIS 1,020,347, approximately $317,371.
- Repayment is subject to the Company having available free cash, as defined in the amendment.
- The filing does not provide clear values for revenue, profit, margins, operating cash flow, total cash, broader debt, or other liquidity metrics.
Material Changes Versus the Prior Arrangement
The amendment changes the repayment terms under the loan agreement originally dated May 9, 2021, and amended and restated on June 30, 2021. Outstanding amounts are to be repaid in 24 equal monthly payments beginning February 4, 2024, subject to available free cash. The amendment also clarifies the total amount owed to Mr. Gottlieb.
Outlook, Risks, Contingencies, and Unusual Items
- The repayment schedule is contingent on available free cash, which may affect the timing of debt repayment.
- The lender group includes the Company’s Chief Executive Officer, director, and largest shareholder, Israel Bar, and a director and second-largest shareholder, Joseph Gottlieb, creating a related-party financing arrangement.
- The amendment was approved by the Board and Audit Committee in accordance with Israeli corporate law.
- No revenue guidance, earnings outlook, or additional operating commentary is included.
- The full amendment is filed as Exhibit 10.1 and incorporated by reference into the Company’s Form S-8 registration statement.
Key Facts for Investors to Verify
- Review Exhibit 10.1 for the complete repayment mechanics, definitions of available free cash, interest terms, and other covenants.
- Verify the Company’s cash position and projected free cash availability before the February 2024 repayment commencement date.
- Assess the related-party nature of the loan and the applicable Board and Audit Committee approvals.
- Reconcile the stated NIS balances and approximate U.S. dollar amounts to the Company’s subsequent financial statements and filings.